Perfect Corp. to Announce Financial Results for the First Nine Months of 2022 on November 30, 2022

NEW YORK--(BUSINESS WIRE)--Perfect Corp. (NYSE: PERF) ("Perfect" or the "Company"), a global leader in providing…

“TICK TOCK, TICK TOCK” Outdoor Public Art Exhibition Giant 8-Metre-Tall Gummy Bear Sculpture at the Tsim Sha Tsui Clock Tower From now until 1 January 2023

HONG KONG--(BUSINESS WIRE)--Presented by First Initiative Foundation (FIF) and supported by the Hong Kong Tourism…

DEXLEVO at AMWC JAPAN: a Successful Debut

SEOUL, South Korea--(BUSINESS WIRE)--DEXLEVO, a company specializing in beauty medical devices, attended the Aesthetic and…

VinES and Gotion High-Tech break ground at a 5GWh/year LFP battery factory

HA TINH, VIETNAM - Media OutReach - 18 November 2022 - Today, VinES Energy Solutions…

Bybit Kicks Off World Cup Fever with Crypto Fan Token Competition

VICTORIA, SEYCHELLES - Media OutReach - 18 November 2022 - Bybit, one of the world's…

South Korea Foodservice Market Report 2022 to 2027 – Growing Demand for Online Delivery Services of Meals – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "South Korea Foodservice Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 -…

EdiGene Announces Completion of Last Patient Dosing in Phase I Clinical Trial of ET-01, its Investigational Gene-editing Hematopoietic Stem Cell Therapy for Transfusion Dependent ?-thalassemia

BEIJING & WALTHAM, Mass.--(BUSINESS WIRE)--EdiGene, Inc., a global, clinical-stage company focused on translating gene-editing technologies…

Fair Go Casino Launch $10,000 Cash Tourney and Their Black Friday Sale

Your chance to compete for Fair Go’s biggest prize pool yet SYDNEY--(BUSINESS WIRE)--This. Is. Big.…

iFREE Teams Up With U Mobile To Showcase Next-Gen Technology via TROLLEE P1 at Smart Nation Expo 2022

HONG KONG--(BUSINESS WIRE)--iFREE GROUP, a global smart technology and connectivity company, teamed up with U…

Patrys Appoints Global Biotechnology Leader as Chairman – In Preparation for First Clinical Trial for Groundbreaking Cancer Therapy

MELBOURNE, Australia--(BUSINESS WIRE)--Patrys Limited (ASX: PAB, “Patrys” or the “Company”), a therapeutic antibody development company,…